ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $19,047,000 | +74.2% | 110,683 | +27.0% | 0.03% | +77.8% |
Q2 2021 | $10,936,000 | +28678.9% | 87,160 | +30698.6% | 0.02% | – |
Q1 2021 | $38,000 | -98.1% | 283 | -98.7% | 0.00% | -100.0% |
Q2 2020 | $2,021,000 | -35.5% | 21,223 | -39.1% | 0.01% | -37.5% |
Q1 2020 | $3,131,000 | +18.3% | 34,866 | -30.1% | 0.01% | +60.0% |
Q4 2019 | $2,646,000 | +39.9% | 49,915 | +4.3% | 0.01% | +25.0% |
Q3 2019 | $1,891,000 | +80.4% | 47,839 | +87.6% | 0.00% | +100.0% |
Q2 2019 | $1,048,000 | -11.6% | 25,506 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,186,000 | +38.6% | 25,506 | +29.9% | 0.00% | 0.0% |
Q4 2018 | $856,000 | +113.5% | 19,637 | +179.8% | 0.00% | +100.0% |
Q3 2018 | $401,000 | +88.3% | 7,017 | +50.5% | 0.00% | – |
Q2 2018 | $213,000 | -15.8% | 4,663 | -27.9% | 0.00% | – |
Q1 2018 | $253,000 | +5.9% | 6,463 | +17.1% | 0.00% | – |
Q4 2017 | $239,000 | -86.3% | 5,519 | -88.2% | 0.00% | -100.0% |
Q3 2017 | $1,742,000 | +187.9% | 46,684 | +134.5% | 0.00% | +200.0% |
Q2 2017 | $605,000 | -17.9% | 19,911 | -28.5% | 0.00% | 0.0% |
Q1 2017 | $737,000 | +95.0% | 27,850 | +88.9% | 0.00% | 0.0% |
Q4 2016 | $378,000 | – | 14,742 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |